ACC 2017Acute Coronary Syndrome SPIRE 1 and SPIRE 2: Safety and cardiovascular efficacy of bococizumab Medhat Share 0 Min Read http://cardiologynownews.org/wp-content/uploads/2017/12/1971-1939.mp4 TAGGED:ACC 2017bococizumabConference Share This Article Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment.
